Previous studies have indicated that increase in pro-apoptotic proteins Bax and Bak with decreased levels of anti-apoptotic proteins like Bcl-2 in both total and mitochondrial fractions are a major driving force in mitochondrial dysfunction and subsequent apoptosis in some anti-cancer treatments [16, 25, 29, 31–33]. Here, BCL2 is linked to cancer.